论文信息 - Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry’s disease during enzyme-replacement therapy - 字舞流文

Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry’s disease during enzyme-replacement therapy

D. Horstkotte | L. Faber | C. Prinz | M. Farr | D. Hering

[1] F. Weidemann,et al. Use of tissue Doppler imaging to identify and manage systemic diseases , 2008, Clinical Research in Cardiology.

[2] Oliver Turschner,et al. Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease: A Prospective Strain Rate Imaging Study , 2003, Circulation.

[3] G. Abor,et al. Safety and efficacy of recombinant human alpha-galactosidase a replacement therapy in Fabry's disease , 2001 .

[4] G. Abor,et al. Uva-dare (digital Academic Repository) Safety and Efficacy of Recombinant Human Alpha-galactosidase a Replacement Therapy in Fabry's Disease Safety and Efficacy of Recombinant Human a -galactosidase a Replacement Therapy in Fabry's Disease , 2022 .